Here Comes Obesity Drug Competition: Amgen Shares Soar On "Very Encouraging" Clinical Trial Update
Here Comes Obesity Drug Competition: Amgen Shares Soar On “Very Encouraging” Clinical Trial Update Amgen’s shares soared in premarket trading in New York following the drug maker’s announcement of “very encouraging” clinical trial results for its new injectable weight-loss drug, “MariTide.” Amgen’s MariTide is poised to compete with Eli Lilly & Co’s Zepbound and Novo Nordisk A/S’ Wegovy, both blockbuster […]
Discuss on Nostr!
Nostr Note ID note1436h2z3we60ymcp2xkecr54enaf0wyzh6cgygyeewcfygm8zhtdq2yk3cv Open on Primal.net Open on Snort.social Open on Iris.to Open on Coracle.social
New to Nostr?
Create an account now & join the conversation!
Promote it on DissentWatch!
- To advertise this post for $0.02 per visit send bitcoins to the address below
- The post will be promoted daily via social media & our "Featured News" display in multiple places
- You can add more anytime
- Ranking order in the Featured News box is based on the balance remaining
Received: 0 mBTC (0.00 USD)
Spent: 0 mBTC (0.00 USD)
Balance: 0 mBTC (0.00 USD)
The amounts above may be lagging behind. If you just sent a payment click below to get more up to date results and push the post to the "Featured News" box faster.